PROSTONIL

Prostonil Capsule is formulated with a lipid extract derived from serenoa repens, which plays a role in addressing urinary issues linked to benign prostatic hyperplasia (BPH). This condition typically manifests as an enlarged prostate, leading to various urinary symptoms. The presence of serenoa repens in this capsule is significant for those experiencing symptoms related to early (stage I) and moderate (stage II) BPH. By promoting a reduction in prostate size, the capsule can facilitate improved urine flow, potentially alleviating difficulties such as straining or urgency. Additionally, individuals who suffer from nocturia, or frequent nighttime urination, may find relief through the consistent use of this formulation. Regular consumption of Prostonil can contribute to a better quality of life for those affected by BPH. It is important to adhere to guidelines provided by healthcare professionals for optimal results and safety. Always consult a medical practitioner for personalized advice regarding prostate health and the management of associated urinary concerns. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.